PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.680
-0.030 (-1.75%)
Nov 21, 2024, 10:40 AM EST - Market open
PharmaCyte Biotech Employees
PharmaCyte Biotech had 2 employees as of April 30, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
$2,247,667
Market Cap
12.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Vivos Therapeutics | 123 |
Cosmos Health | 123 |
Psychemedics | 116 |
Ekso Bionics Holdings | 72 |
Microbot Medical | 22 |
Traws Pharma | 18 |
Minerva Neurosciences | 9 |
Can-Fite BioPharma | 8 |
PMCB News
- 6 months ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire
- 6 months ago - PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease - Business Wire
- 1 year ago - PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc. - Business Wire
- 1 year ago - PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology - Business Wire
- 1 year ago - PharmaCyte Biotech Announces Final Results of Tender Offer - Business Wire
- 1 year ago - PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share - Business Wire
- 1 year ago - PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan - Business Wire
- 2 years ago - PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value - GlobeNewsWire